Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocyte Function-Associated Antigen-1 | 6 | 2000 | 72 | 0.580 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2011 | 82 | 0.490 |
Why?
|
| Neutrophils | 7 | 2000 | 835 | 0.470 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 223 | 0.440 |
Why?
|
| Synovitis | 1 | 2011 | 23 | 0.410 |
Why?
|
| Arthritis, Infectious | 1 | 2012 | 68 | 0.410 |
Why?
|
| Anemia | 2 | 2015 | 689 | 0.400 |
Why?
|
| Candida | 1 | 2012 | 164 | 0.380 |
Why?
|
| Arthritis | 1 | 2011 | 139 | 0.380 |
Why?
|
| Candidiasis | 1 | 2012 | 262 | 0.360 |
Why?
|
| Hydrogen Peroxide | 2 | 2000 | 217 | 0.350 |
Why?
|
| Primary Myelofibrosis | 2 | 2015 | 831 | 0.350 |
Why?
|
| Macrophage-1 Antigen | 6 | 2000 | 51 | 0.310 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2000 | 221 | 0.290 |
Why?
|
| Cell Adhesion | 8 | 2000 | 1008 | 0.260 |
Why?
|
| CD18 Antigens | 6 | 2003 | 83 | 0.230 |
Why?
|
| Respiratory Burst | 2 | 2000 | 23 | 0.200 |
Why?
|
| Diagnosis, Differential | 4 | 2015 | 4744 | 0.190 |
Why?
|
| Autoimmune Diseases | 2 | 2015 | 402 | 0.170 |
Why?
|
| Cell Movement | 3 | 1999 | 2466 | 0.130 |
Why?
|
| Hematologic Tests | 1 | 2015 | 82 | 0.130 |
Why?
|
| Triazoles | 2 | 2013 | 617 | 0.110 |
Why?
|
| Myocardium | 1 | 2000 | 1313 | 0.110 |
Why?
|
| Synovial Fluid | 1 | 2012 | 27 | 0.110 |
Why?
|
| Chondrocalcinosis | 1 | 2012 | 19 | 0.110 |
Why?
|
| Arthralgia | 1 | 2013 | 89 | 0.110 |
Why?
|
| Drug Resistance, Fungal | 1 | 2012 | 92 | 0.100 |
Why?
|
| Rheumatic Diseases | 1 | 2011 | 54 | 0.100 |
Why?
|
| Knee Joint | 1 | 2012 | 161 | 0.100 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2007 | 1039 | 0.100 |
Why?
|
| Dogs | 4 | 2000 | 1155 | 0.100 |
Why?
|
| Bone Diseases | 1 | 2011 | 143 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2000 | 2819 | 0.090 |
Why?
|
| Growth Plate | 1 | 2010 | 46 | 0.090 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 2 | 2000 | 6 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 84 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2012 | 829 | 0.090 |
Why?
|
| Chondrocytes | 1 | 2010 | 107 | 0.090 |
Why?
|
| Bone Resorption | 1 | 2010 | 138 | 0.090 |
Why?
|
| Neoplasms | 3 | 2011 | 15193 | 0.080 |
Why?
|
| Chemotactic Factors | 2 | 2000 | 42 | 0.080 |
Why?
|
| Nitriles | 1 | 2013 | 906 | 0.080 |
Why?
|
| E-Selectin | 3 | 2010 | 103 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 840 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2015 | 2358 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 698 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2012 | 834 | 0.070 |
Why?
|
| Kinetics | 2 | 2000 | 2049 | 0.070 |
Why?
|
| bcl-X Protein | 1 | 2005 | 196 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2007 | 241 | 0.060 |
Why?
|
| Homeostasis | 1 | 2010 | 950 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2007 | 291 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1130 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2005 | 207 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2003 | 138 | 0.060 |
Why?
|
| Male | 10 | 2015 | 123000 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2003 | 212 | 0.050 |
Why?
|
| Bone Neoplasms | 2 | 2011 | 2576 | 0.050 |
Why?
|
| Humans | 15 | 2015 | 261506 | 0.050 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2000 | 14 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2005 | 3869 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 582 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 293 | 0.050 |
Why?
|
| Helminth Proteins | 1 | 2000 | 107 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 14289 | 0.040 |
Why?
|
| Azepines | 1 | 2000 | 124 | 0.040 |
Why?
|
| Animals | 13 | 2010 | 59536 | 0.040 |
Why?
|
| Skin Ulcer | 1 | 1998 | 77 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2000 | 891 | 0.040 |
Why?
|
| Mice, Knockout | 6 | 2010 | 5710 | 0.040 |
Why?
|
| Mice | 9 | 2010 | 34495 | 0.040 |
Why?
|
| Thioglycolates | 1 | 1997 | 7 | 0.040 |
Why?
|
| Neutrophil Activation | 1 | 1997 | 34 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1997 | 47 | 0.040 |
Why?
|
| L-Selectin | 1 | 1997 | 34 | 0.040 |
Why?
|
| Peritonitis | 1 | 1997 | 89 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2000 | 747 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2000 | 444 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 634 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2000 | 1442 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 2944 | 0.030 |
Why?
|
| Prolactin | 1 | 1995 | 155 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 1555 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2000 | 157 | 0.030 |
Why?
|
| Inflammation | 2 | 2003 | 2522 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2000 | 5637 | 0.030 |
Why?
|
| Inhibins | 1 | 1994 | 128 | 0.030 |
Why?
|
| Female | 10 | 2013 | 141928 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 6942 | 0.030 |
Why?
|
| Aged | 4 | 2013 | 70117 | 0.030 |
Why?
|
| Cachexia | 1 | 1994 | 161 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2013 | 9244 | 0.030 |
Why?
|
| Adult | 3 | 2015 | 77950 | 0.030 |
Why?
|
| Apoptosis | 1 | 2005 | 7591 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 2011 | 84 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1995 | 1144 | 0.020 |
Why?
|
| Selectins | 1 | 2010 | 6 | 0.020 |
Why?
|
| Furin | 1 | 2010 | 10 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2010 | 151 | 0.020 |
Why?
|
| Stem Cells | 1 | 1997 | 1213 | 0.020 |
Why?
|
| Lung | 2 | 2003 | 3151 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 4367 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1994 | 489 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2010 | 153 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2010 | 270 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1995 | 1152 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 1682 | 0.020 |
Why?
|
| Cell Line | 1 | 1997 | 5114 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2013 | 953 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1995 | 1555 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 15694 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 619 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2005 | 6089 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 652 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 995 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 476 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 140 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 3154 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 1171 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 8865 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2005 | 311 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 15862 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 187 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 4233 | 0.020 |
Why?
|
| Growth Substances | 1 | 2005 | 300 | 0.020 |
Why?
|
| Interleukin-8 | 2 | 1997 | 519 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 1 | 2003 | 18 | 0.010 |
Why?
|
| Leishmania major | 1 | 2003 | 21 | 0.010 |
Why?
|
| SEER Program | 1 | 2007 | 1000 | 0.010 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2003 | 46 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 4053 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2003 | 284 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 5673 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4143 | 0.010 |
Why?
|
| Medicare | 1 | 2007 | 860 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1487 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 4821 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 17523 | 0.010 |
Why?
|
| Failure to Thrive | 1 | 2000 | 91 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1999 | 9 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 145 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2000 | 684 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1999 | 334 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4078 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 2170 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2000 | 408 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 690 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1999 | 311 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 2314 | 0.010 |
Why?
|
| Zymosan | 1 | 1998 | 10 | 0.010 |
Why?
|
| Leukocytes | 1 | 2000 | 422 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 4917 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1998 | 112 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 185 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 7222 | 0.010 |
Why?
|
| Phenotype | 2 | 2000 | 6295 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2000 | 749 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 29902 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 943 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2000 | 935 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2010 | 11965 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 1998 | 330 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1996 | 55 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 1293 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2000 | 1581 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1997 | 475 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 1995 | 53 | 0.010 |
Why?
|
| Rhinovirus | 1 | 1995 | 94 | 0.010 |
Why?
|
| Neoplasms, Gonadal Tissue | 1 | 1994 | 3 | 0.010 |
Why?
|
| Skin | 1 | 2000 | 1259 | 0.010 |
Why?
|
| Picornaviridae Infections | 1 | 1995 | 57 | 0.010 |
Why?
|
| Activins | 1 | 1994 | 98 | 0.010 |
Why?
|
| Malaria | 1 | 1995 | 92 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 1688 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 220 | 0.010 |
Why?
|
| S Phase | 1 | 1995 | 281 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1995 | 156 | 0.010 |
Why?
|
| Gene Library | 1 | 1995 | 294 | 0.010 |
Why?
|
| G1 Phase | 1 | 1995 | 285 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 1538 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 2489 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1994 | 214 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1995 | 339 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12221 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 777 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 469 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 869 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1313 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 997 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1994 | 330 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1998 | 1146 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 13658 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 2171 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 2927 | 0.010 |
Why?
|
| United States | 1 | 2007 | 15433 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 21713 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 3438 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 2483 | 0.000 |
Why?
|
| Rats | 1 | 1995 | 6086 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1996 | 6150 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 86204 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 37905 | 0.000 |
Why?
|